Methotrexate in rheumatoid arthritis.
Furst
D E
DE
Department of Medicine, University of Iowa, Iowa City 52242.
Kremer
J M
JM
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001772:Blood Cell Count / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D002273:Carcinogens / Q000494:pharmacology; D002493:Central Nervous System Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D003875:Drug Eruptions; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008171:Lung Diseases / Q000139:chemically induced; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013280:Stomatitis / Q000139:chemically induced; D013723:Teratogens / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D002273:Carcinogens; D007166:Immunosuppressive Agents; D013723:Teratogens; D008727:Methotrexate